Your browser doesn't support javascript.
loading
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee, Andrew W; Liu, Ken; Lhomme, Edouard; Blie, Julie; McCullough, John; Onorato, Matthew T; Connor, Laurie; Simon, Jakub K; Dubey, Sheri; VanRheenen, Susan; Deutsch, Jonathan; Owens, Abigail; Morgan, Amy; Welebob, Carolee; Hyatt, Donna; Nair, Sunita; Hamzé, Benjamin; Guindo, Oumar; Sow, Samba O; Beavogui, Abdoul H; Leigh, Bailah; Samai, Mohamed; Akoo, Pauline; Serry-Bangura, Alimamy; Fleck, Suzanne; Secka, Fatou; Lowe, Brett; Watson-Jones, Deborah; Roy, Céline; Hensley, Lisa E; Kieh, Mark; Coller, Beth-Ann G.
Affiliation
  • Lee AW; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Liu K; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Lhomme E; Inserm, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, University of Bordeaux, Bordeaux, France.
  • Blie J; Partnership for Research on Ebola Vaccines in Liberia (PREVAIL), Monrovia, Liberia.
  • McCullough J; Advanced BioMedical Laboratories (ABML), Cinnaminson, New Jersey, USA.
  • Onorato MT; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Connor L; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Simon JK; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Dubey S; Merck & Co., Inc., Rahway, New Jersey, USA.
  • VanRheenen S; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Deutsch J; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Owens A; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Morgan A; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Welebob C; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Hyatt D; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Nair S; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Hamzé B; Pôle Recherche Clinique, Institut National de la Santé et de la Recherche Médicale (Inserm), Paris, France.
  • Guindo O; University Clinical Research Center (UCRC), Bamako, Mali.
  • Sow SO; CVD-Mali, Bamako, Mali.
  • Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR), Maferinyah, Guinea.
  • Leigh B; College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
  • Samai M; College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
  • Akoo P; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
  • Serry-Bangura A; College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
  • Fleck S; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
  • Secka F; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
  • Lowe B; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
  • Watson-Jones D; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
  • Roy C; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Hensley LE; Inserm, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, University of Bordeaux, Bordeaux, France.
  • Kieh M; University of Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France.
  • Coller BG; National Bio and Agro-Defense Facility (NBAF), United States Department of Agriculture (USDA), Manhattan, Kansas, USA.
Clin Infect Dis ; 78(4): 870-879, 2024 Apr 10.
Article de En | MEDLINE | ID: mdl-37967326
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fièvre hémorragique à virus Ebola / Vaccins contre la maladie à virus Ebola / Ebolavirus Limites: Adult / Child / Humans Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fièvre hémorragique à virus Ebola / Vaccins contre la maladie à virus Ebola / Ebolavirus Limites: Adult / Child / Humans Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique